AppLovin heads into its August 5 earnings report with a two-week slide on the tape and options traders pricing in more caution than at any point in the past year.
The options picture is the most telling signal this week. The put/call ratio has climbed to 0.86 — more than two standard deviations above its 20-day average of 0.81, the highest defensive skew in the past 52 weeks. That reading has been rising steadily since mid-July, when the prior note flagged the ratio at 0.83. The drift higher is consistent: investors are adding downside protection as the August 5 print approaches, not retreating from it. With the stock now at $428.69 — down another 4.5% on the week and nearly 9% over the past month — the accumulation of put hedges looks less like speculation and more like portfolio insurance on a stock that has already disappointed twice in the recent past.
Short interest, by contrast, continues to tell a quieter story. Bears have now cut their exposure for the fifth consecutive week. Short interest fell a further 2.7% on the week to roughly 11.7 million shares, equal to 3.8% of the free float — down from above 13 million in late June. The covering trend that began after the stock's 15% weekly drop in mid-July is still intact. Borrow costs are negligible at 0.50% and availability is extraordinary, with more than 25 shares available to lend for every one already borrowed. The ORTEX short score has eased to 36.9, a fresh low for this period. Positioning looks optionally cautious but short-side uncrowded — the bears who were in this trade have largely left it.
The Street remains broadly constructive, but the stock has drifted well below the analyst consensus. The mean price target of $654.60 implies roughly 53% upside from current levels — a gap wide enough to flag as a valuation tension rather than a straightforward bullish signal. Most recent analyst activity has been at the margins: Wells Fargo nudged its target to $575 in early July while holding Overweight, and Raymond James initiated with Strong Buy at $640 at the end of June. The bull case centres on Axon Pixel adoption, 51% projected Q1 revenue growth, and expanding EBITDA margins. Bears point to gaming-revenue dependency, limited disclosure around the e-commerce segment, and the opacity of the AXON 2 optimizer — concerns that are not new, but that carry more weight after a stock has shed nearly a third of its value from peak levels. The analyst-recommendation divergence factor scores in the 94th percentile, one of the strongest signals in the dataset, suggesting the Street consensus is considerably more positive than the price action.
Earnings history adds context without offering comfort. The last print on June 3 sent the stock down 7.7% the next day and 18.6% over the subsequent five days — a severe five-day reaction. The print before that, in May, was roughly flat on the day but gave back ground over the week. The pattern across recent quarters has been asymmetric: the post-earnings relief has been modest when results are good, and the drawdowns have been steep when they disappoint. That history partly explains why options traders are paying for downside protection now rather than waiting.
Among correlated peers, ZETA lost 5.9% on the week and QBTS fell 6.1%, suggesting the broader ad-tech and software-adjacent cohort has faced the same headwinds. PLTR held up better, off less than 1% on the week, while CLBT was the week's laggard at down 8.8%. AppLovin's 4.5% weekly decline sits near the middle of its peer group — neither the worst performer nor a shelter from the storm.
What to watch into August 5: whether the put/call ratio continues its creep toward the 52-week high of 0.92 as the print approaches, and whether short interest — which has now covered a quarter of its late-June peak — stabilises or edges back up if the stock catches a pre-earnings bid.
See the live data behind this article on ORTEX.
Open APP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
